Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
1.
BMC Geriatr ; 23(1): 157, 2023 03 21.
Artículo en Inglés | MEDLINE | ID: mdl-36944957

RESUMEN

BACKGROUND: Frailty is a state of increased vulnerability to poor resolution of homeostasis following a stress. Early diagnosis and intervention of frailty are essential to prevent its adverse outcomes. However, simple diagnostic criteria have not been established. The Questionnaire for Medical Checkup of Old-Old (QMCOO) is widely used for medical checkups of older adults in Japan. In our previous report, we developed a method to score the QMCOO and showed that frailty can be diagnosed with the highest accuracy when the score cutoff was set at 3/4 points. We aimed to validate the criteria in a larger cohort. METHODS: Participants aged 65 years or over were recruited in the western region of Japan. They answered all the items of the Kihon Checklist (KCL) and the QMCOO. Based on the KCL score, they were diagnosed as robust (3 or lower), prefrail (4 to 7), or frail (8 or over). Then we tested the effectiveness to diagnose frailty using the QMCOO cutoff of 3/4 points. We also aimed to determine the score cutoff to separate robust and prefrail. RESULTS: 7,605 participants (3,458 males and 4,147 females, age 77.4 ± 6.9 years) were recruited. 3,665 participants were diagnosed as robust, 2,448 were prefrail, and 1,492 were frail based on the KCL score. The diagnosis of frailty had a sensitivity of 84.0%, specificity of 82.5%, and accuracy of 82.8% with a QMCOO score cutoff of 3/4 points, suggesting its validity. To separate robust and prefrail, both the accuracy and the Youden index were the highest with the QMCOO cutoff of 2/3 points (sensitivity, specificity, and accuracy were 63.9%, 83.4%, and 75.6%, respectively). All the questions of the QMCOO except Q12 (about smoking) were significantly related to prefrailty status after a logistic regression analysis. CONCLUSION: Diagnosis of frailty using the QMCOO score cutoff of 3/4 points was validated. Prefrailty could be diagnosed using the score cutoff of 2/3 points.


Asunto(s)
Fragilidad , Masculino , Femenino , Humanos , Anciano , Fragilidad/diagnóstico , Fragilidad/epidemiología , Vida Independiente , Encuestas y Cuestionarios , Examen Físico , Lista de Verificación/métodos , Anciano Frágil , Evaluación Geriátrica/métodos
2.
Geriatr Gerontol Int ; 22(2): 127-131, 2022 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-34894169

RESUMEN

AIM: Although frailty could be reversible by early diagnosis and interventions, it lacks definite diagnostic criteria. The Kihon Checklist is a 25-item questionnaire that diagnoses frailty with a cutoff score of 7/8. The Questionnaire for Medical Checkup of Old-Old (QMCOO) was recently established and used for medical checkups among Japanese older adults, but no method or cutoff score for diagnosing frailty has been established. Thus, we aimed to diagnose frailty using the QMCOO and to determine its cutoff score by comparing it with that of the Kihon Checklist. METHODS: We recruited 223 older adults in Yasugi City and Yonago City to answer all the questions in the Kihon Checklist and the QMCOO at the same time. Those scoring ≥8 for the Kihon Checklist (n = 38) were diagnosed as frail. We also determined the cutoff score for frailty for the QMCOO and examined which questionnaire items affected the frailty status. RESULTS: The QMCOO and the Kihon Checklist score showed a significant positive correlation (r = 0.670, P < 0.001). The area under the curve was 0.851. A cutoff score of 3/4 for the QMCOO represented the best results (sensitivity, 76.3%; specificity, 88.1%; and accuracy, 86.1%). Multiple linear regression analysis revealed that subjective health status, body weight loss, slowness, and forgetfulness still affected the frailty status. CONCLUSIONS: A cutoff score of 3/4 for the QMCOO might be effective in diagnosing frailty. Geriatr Gerontol Int 2022; 22: 127-131.


Asunto(s)
Fragilidad , Anciano , Anciano Frágil , Fragilidad/diagnóstico , Evaluación Geriátrica , Humanos , Vida Independiente , Japón , Encuestas y Cuestionarios
3.
J Med Chem ; 48(16): 5279-94, 2005 Aug 11.
Artículo en Inglés | MEDLINE | ID: mdl-16078846

RESUMEN

Prostacyclin (PGI(2)) is an unstable, powerful endogenous inhibitor of platelet aggregation, and thromboxane A(2) (TXA(2)) is an unstable endogenous arachidonic acid metabolite that plays a pivotal role in platelet aggregation and vasoconstriction. The balance between TXA(2) and PGI(2) greatly affects maintenance of the homeostasis of the circulatory system. A novel series of benzofuran-7-yloxyacetic acid derivatives was discovered as potent dual-acting agents to block the thromboxane A(2) receptor and to activate the prostacyclin receptor. Synthesis, structure-activity relationship, and in vitro and ex vivo pharmacology of this series of compounds are described. The most potent in the series was {3-[2-(1,1-diphenylethylsulfanyl)ethyl]-2-hydroxymethylbenzofuran-7-yloxy}acetic acid diethanolamine salt (7) with K(i) of 4.5 nM for thromboxane receptor antagonism and K(i) of 530 nM for prostacyclin receptor agonism. Remarkably, compound 7 is a promising candidate for novel treatment as an antithrombotic agent with other cardiovascular actions to avoid hypotensive side effects.


Asunto(s)
Benzofuranos/síntesis química , Fibrinolíticos/síntesis química , Receptores de Epoprostenol/agonistas , Receptores de Tromboxano A2 y Prostaglandina H2/antagonistas & inhibidores , Sulfuros/síntesis química , Animales , Benzofuranos/química , Benzofuranos/farmacología , Sitios de Unión , Presión Sanguínea/efectos de los fármacos , Fibrinolíticos/química , Fibrinolíticos/farmacología , Frecuencia Cardíaca/efectos de los fármacos , Humanos , Técnicas In Vitro , Macaca fascicularis , Masculino , Agregación Plaquetaria/efectos de los fármacos , Ensayo de Unión Radioligante , Relación Estructura-Actividad , Sulfuros/química , Sulfuros/farmacología
4.
Anim Sci J ; 85(3): 247-53, 2014 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-24261715

RESUMEN

This study investigated an objective method for estimating beef marbling using ultrasonic images of the Iliocostalis muscle and the Lomgissimus muscle area sections. Thirty-one Japanese Black cattle steers were used in this study. The end of the left side shoulder blade bone was scanned using an ultrasonic device. Ultrasonic images were captured of the Longissimus muscle area and that around the Iliocostalis muscle area. Twenty items were measured in the two images using computer image analysis software. The level of beef marbling was measured according to the Beef Marbling Standard (BMS) for carcass grading, and the percentage of ether-extractable fat content in the Longissimus muscle (EE). The difference in the gray level between the Iliocostalis muscle and intermuscular fat (X10) was used to estimate the BMS and the EE, which were highly correlated (r(2) = 67.72% and 61.30%). An equation was developed using four parameters from the two ultrasonic images, which could estimate the BMS (r(2) = 85.88%). This equation could also estimate the EE (r(2) = 68.98%). The equations used to estimate beef marbling were based on one to four parameters that included X10. Thus, ultrasonic images of the Iliocostalis muscle area section are important for estimating beef marbling.


Asunto(s)
Tejido Adiposo/anatomía & histología , Bovinos/anatomía & histología , Procesamiento de Imagen Asistido por Computador/métodos , Músculos Paraespinales/anatomía & histología , Músculos Paraespinales/diagnóstico por imagen , Tejido Adiposo/diagnóstico por imagen , Animales , Masculino , Ultrasonografía
5.
Bioorg Med Chem ; 14(6): 2005-21, 2006 Mar 15.
Artículo en Inglés | MEDLINE | ID: mdl-16297632

RESUMEN

We discovered a novel series of 3,4-dihydro-2H-benzo[1,4]oxazin-8-yloxyacetic acid derivatives as potent dual-acting agents to block the TXA2 receptor and to activate the PGI2 receptor. We report the synthesis, structure-activity relationship, and in vitro, ex vivo, and in vivo pharmacology of this series of compounds. 4-[2-(1,1-Diphenylethylsulfanyl)ethyl]-3,4-dihydro-2H-benzo[1,4]oxazin-8-yloxyacetic acid N-methyl-D-glucamine salt (7) is a promising candidate for a novel treatment in the anti-thrombotic and the cardiovascular fields avoiding hypotensive side effects.


Asunto(s)
Benzoxazinas/química , Benzoxazinas/farmacología , Receptores de Epoprostenol/agonistas , Receptores de Tromboxano A2 y Prostaglandina H2/antagonistas & inhibidores , Animales , Benzoxazinas/síntesis química , Plaquetas/química , Plaquetas/metabolismo , Membrana Celular/química , Membrana Celular/metabolismo , Células Cultivadas , Evaluación Preclínica de Medicamentos , Sinergismo Farmacológico , Fibrinolíticos/síntesis química , Fibrinolíticos/química , Fibrinolíticos/farmacología , Humanos , Macaca fascicularis , Masculino , Estructura Molecular , Relación Estructura-Actividad
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA